We have analysed the expression of three calciumindependent isoforms of protein kinase C (PKC), PKCd, PKCe and PKCz, in 
Protein kinase C (PKC) is a family of at least 11 isoenzymes which are commonly divided into three major classes, according to sequence homology and activation properties. The`c' (conventional) class of PKC comprises the calcium-and diacylglycerol (DAG)-activated a, bI, bII and g subtypes. It is believed that this PKC class is important in`shortterm', receptor-mediated cellular responses to transient changes in cytosolic calcium, e.g. hormone secretion, neuromediator release, smooth muscle contraction (reviewed in Blobe et al., 1996) . While the activation mechanism of`c' PKCs is well characterized, little is known about the cofactors required for activation of the calcium-and DAG-independent`a' (atypical) PKCs: l, z and i. Nevertheless, expression studies suggest the involvement of members of this class of PKC in growth-related cellular events (reviewed in Perletti and Monti, 1996) .
The`n' (novel) class of PKC comprises four calciumindependent, DAG-activated isoenzymes, d, e, y and Z. These isoforms are likely to be involved in`long-term' cellular regulation, e.g. cell growth, dierentiation and tumor promotion, possibly relying for activation on DAGs generated by sustained phosphatidylcholine turnover (Blobe et al., 1996) .
It has been demonstrated that PKCe and PKCd can have dierent or even opposite eects on cell growth, morphology, anchorage-dependence and tumorigenicity in several cell models. In fact, a growing body of evidence indicates that PKCe acts as an oncogene in rodent ®broblasts (Mischak et al., 1993a; Cacace et al., 1993) , as well as in colonic epithelial cells . It has been shown that this novel oncogene is likely to exert its transforming action by interacting with the ras signaling pathway, at the level of ras-Raf-1 interaction (Cacace et al., 1996; Cai et al., 1997; Perletti et al., 1998) . Whereas several authors favor a direct action of PKCe on Raf-1 (Cai et al., 1997) , other data suggest that the eect is indirect, via the secretion of autocrine growth factors (Ueng et al., 1997) .
Interestingly, the closely-related PKCd isoform displays cellular eects far dierent from those shown by PKCe. While overexpression of PKCe induced full neoplastic transformation in NIH3T3 cells, transfection of PKCd decreased growth rate, reduced cell density at con¯uency and inhibited anchorage-dependent growth in the same cell type (Mischak et al., 1993a) . A similar eect on cell growth was obtained by Watanabe and coworkers in CHO cells (Watanabe et al., 1992) . On treatment with PKC-activating concentrations of phorbol 12-myristate 13-acetate (PMA), the growth of PKCd-overexpressing CHO cells was arrested, and cells accumulated in the G2/M phase of the cell cycle. Moreover, it has been shown that overexpression of PKCd enabled the mouse myeloid progenitor cell line 32D to dierentiate after treatment with PMA (Mischak et al., 1993b) . In aggregate, these data support the hypothesis that PKCd acts as a negative regulator of cell proliferation and transformation.
To study the role of the PKC family in src-induced colonic cell transformation, we have utilized a speci®c model developed by Pories and coworkers (1993) As an initial step in investigating the role of PKC in src-induced neoplastic transformation, we analysed the levels of the calcium-independent d, e and z isoenzymes in D/WT and D/src cells by Western immunoblot. No other calcium-indepedent PKC subspecies belonging to the`n' and`a' classes are expressed in the`D' cell system . As shown in Figure 1 In a previous report , we have shown that, compared to the D/WT line, PKCe was found to be overexpressed in Ha-ras-transformed D/ras cells, whereas no dierences were observed in PKCd and PKCz expression at the protein level. Therefore, since PKCe is overexpressed in D/ras, but not in D/src cells, and since PKCd is downregulated in D/src but not in D/ras cells compared to the D/WT line, it appears that in colon oncogenesis, as modeled in D/ WT, D/ras and D/src rat epithelial cells, modulation of n' PKC isoform expression is strictly related to the speci®c oncogenic pro®le displayed by the transformed cell lines. Moreover, our studies suggest that PKCz is not involved quantitatively in either src-or rasmediated cell transformation. Our data are consistent with a previous report on PKCd, it has been shown that this isoenzyme is downregulated in the colonic tissue of rats treated with the colorectal carcinogen azoxymethane. Interestingly, dietary ®sh oil can induce a signi®cant decrease of tumor incidence in this model, likely by increasing the steady-state levels of cytosolic PKCd .
Because evidence is accumulating to suggest that PKCd is involved in suppression of cell growth in several cell types, we focused on the role of this isoform in the regulation of proliferation and src- Figure 1 Immunoblot analysis of PKCd (*80 kDA), e (*90 kDa) and z (*75 kDa) in D/WT and D/src cells. Cells were grown to subcon¯uence in 75 cm 2¯a sks and trypsinized. Cell suspensions were washed in PBS and resuspended in 20 ml lysis buer (10 mM Tris, pH 7.5; 1 mM EDTA; 1 mM phenylmethylsulfonyl¯uoride; 10 mg/ml leupeptin, 1% Triton X-100) per 10 6 cells. Cells were then sonicated and the material cleared in an Eppendor microfuge at maximum speed for 20 min. Supernatant solutions were mixed with an equal volume of 26Laemmli sample buer and boiled. 50 mg protein for each sample were loaded on a 10% polyacrylamide gel and electrophoresed. Proteins were transferred onto a nitrocellulose membrane by electrotransfer, incubated for 1 h with 5% nonfat dry milk, exposed for 1 h to PKC isoform-speci®c rabbit polyclonal antibodies (2 mg/ml; Gibco BRL/Life, Italy; Boehringer Mannheim, Italy), and ®nally washed in PBS. To visualize immunoreactive bands, a chemiluminescence kit (Boehringer Mannheim, Italy) was used. (Sambrook et al., 1989) . Rat PKCd cloned in the phagemid vector pBluescript SK(7) was transformed into the bacterial strain CJ 236. Transformed bacteria were subsequently infected with the helper phage M13KO7. Phage single-stranded DNA was then exposed to a mutagenic oligonucleotide (sequence: AAG TAC TTT GCA ATC AAG TGT CTG AAG AAG GAC GTG GTG). To facilitate the screening for mutants, an additional point mutation was introduced to generate a A¯II restriction site, without aecting the amino acid sequence. A cycle of annealing and synthesis in the presence of T7 DNA polymerase, ligase and deoxy nucleotides generated a hybrid phagemid, which was transformed in the DH5a E. coli cells and screened for the introduced mutations by restriction analysis and by automated sequencing. DNd was ®nally subcloned into the pBABE vector (provided by JP Morgenstern, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK; described in Morgenstern and Land, 1990) , under the transcriptional control of the 5' long terminal repeat of Moloney murine leukemia virus. This vector includes the selectable marker hygromycin B phosphotransferase under the transcriptional control of the SV40 early promoter induced neoplastic transformation in our colonic cell model.
Overexpression of a kinase-defective PKCd sequence in D/WT cells
To determine whether downregulation of PKCd could be a relevant step in transformation of D/WT cells, we transfected by the calcium phosphate technique (Sambrook et al., 1989 ) the D/WT line with a kinasedefective PKCd sequence (PKC-DNd) to generate the D/DNd line. To this aim, a point-mutation was generated in the PKCd coding sequence by substituting the ATP-binding lysine 376 with an arginine (K376R) in the catalytic site of the enzyme. This mutation is known to generate kinase-defective forms of PKC displaying dominant-negative activity when overexpressed in mammalian cells (Wang et al., 1998) . D/DNd cells, obtained as bulk-cultures after selection with 50 mg/ml hygromycin B, were smaller, less attened and more refractile (Figure 2a ) than D/WT cells (Figure 2b ), or mock-transfected D/WT cells (not shown). The growth parameters of all tested cell lines, analysed as previously described , are shown in Table 1 . D/DNd cells were able to form transformed foci at postcon¯uence (Table 1 and (Figure 4e) . In some cases, cells became¯attened, vacuolized giant polykaryons (Figure 4f ). The growth parameters of all cell lines, analysed as previously described are shown in Table 1 . Compared to D/src cells, D/src/d cells displayed a signi®cant impairment of both growth rate and saturation density during phase 1. Consistently, in vitro transformation characteristics were signi®cantly altered in D/src/d cells, which were unable to form transformed foci when grown to postcon¯uence, and displayed a highly attenuated capacity of anchorage-independent growth. In fact, whereas D/src cells were able to form very large, rapidly growing, dense colonies in soft agar (Figure 5a) at 62% eciency (Table 1) , the D/src/d line formed a lower number (eciency=27%) of small cell clusters (Figure 5b ), which were unable to form larger colonies, and degenerated at later times. As expected, the mixed cell population composed by normal-sized and multinucleated giant cells ( The mechanisms responsible for PKCd-induced growth arrest are still under investigation. In particular, it is not yet clear which downstream targets might be selected by PKCd to elicit its growth and tumor suppressor activity, although an action on elements involved in cell cycle control are likely. It has been demonstrated that PKCd can block CHO cells in the G2/M phase of the cell cycle (Watanabe et al., 1992) . Accordingly, a model proposed in a recent review suggests that PKCd may act as an inhibitor of the G2-M transition by downregulating Cdc25, a phosphatase responsible for activation of Cdc2 kinase (Livneh and Fishman, 1997) .
In a recent report, Zang and coworkers have demonstrated that in v-src-transformed 3Y1 rat ®broblasts, PKCd associated with and is tyrosinephosphorylated by src. Interestingly, phosphorylation by src induces a marked decrease of PKCd activity, suggesting that impaired activity of this isoenzyme may be associated with src transformation. Furthermore, Lu et al. (1997) have shown that overexpression of c-src alone was not sucient to induce a transformed phenotype in 3Y1 cells, and that continuous exposure to PMA was required to elicit full transformation. Similar results were obtained when certain PKC inhibitors were used in place of PMA. This eect correlated with the downregulation of PKCs a and d. Exposure to the PKC activator bryostatin 1 prevented both PMA-induced transformation and PKCd downregulation, suggesting involvement of this isoform in src transformation. Thus, exposure to a PKCd-selective inhibitor or transfection with a dominant-negative sequence of this isoform induced anchorage-independent growth in cells overexpressing c-src. Therefore, it appears that a functional relationship exists between src transformation and downregulation of PKCd expression and/or enzymatic activity, implying a crucial regulatory role for PKCd in src-mediatd oncogenesis.
Our ®ndings support this model. In fact, overexpression of wild-type PKCd cDNA reverted the transformed phenotype displayed by D/src cells, and even arrested cell proliferation at later stages in culture. Moreover, a kinase-defective, dominant-negative PKCd mutant evoked morphologic features of growth abnormalities related to partial cell transformation in D/WT cells. In contrast to the ®ndings of Lu et al. (1997) , we did not observe full in vitro transformation upon transfection with dominant-negative PKCd. This may be explained by the absence in our experiment of a co-transfected c-src sequence, which apparently cooperates with PKC-DNd to induce a fully transformed phenotype in 3Y1 cells.
In conclusion, our results indicate that PKCd can act to inhibit cell proliferation in src-transformed cells, and that down-modulation of this isoenzyme might be a crucial step in colonic cell oncogenesis. Together with observations by other research groups Zang et al., 1997; Watanabe et al., 1992) , these ®ndings suggest that PKCd is emerging as a novel suppressor of tumor growth and progression, at least in certain cell types.
